Veracyte

veracyte.com

Veracyte is a global genomic diagnostics company that enhances patient care through innovative tests for cancer and other diseases. Their portfolio includes advanced genomic tests for thyroid, prostate, breast, and bladder cancers, as well as interstitial lung disease, which help clinicians make informed decisions and improve patient outcomes. With a focus on accessibility, Veracyte aims to provide high-quality diagnostics globally, leveraging a CLIA- and IVD-based model to ensure widespread availability. The company has benefited over 400,000 patients and addresses a significant market need, with over 7 million people diagnosed with relevant cancers annually.